Episode
How Private Equity Is Buying Up Hemp and CBD Companies
- Published
- Jul 1, 2026
- Duration seconds
- 481
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/the-buyout-show-with-fexingo-private-equity-roll-ups-and-business-acquisitions-7871630/episodes/how-private-equity-is-buying-up-hemp-and-cbd-companies/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/the-buyout-show-with-fexingo-private-equity-roll-ups-and-business-acquisitions-7871630/how-private-equity-is-buying-up-hemp-and-cbd-companies.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Episode 85 of The Buyout Show examines the quiet roll-up of the hemp and CBD industry by private equity. We track one deal: the 2025 acquisition of Charlotte's Web Holdings by a PE-backed platform called Brightfield Group. Lucas walks through the numbers: Charlotte's Web went public in 2018 at a valuation near $1 billion, and by 2025 was acquired for roughly $85 million. Luna pushes on whether the stigma around cannabinoids still scares off institutional LPs. We break down the thesis — consolidation in a fragmented market, FDA clarity on CBD as a dietary supplement, and the playbook resembling the earlier dental and vet roll-ups. We also touch on the challenges: valuation volatility, regulatory whiplash, and the difficulty of scaling a plant-based supply chain. A specific, sober look at the next frontier of PE aggregation. #PrivateEquity #Hemp #CBD #CharlotteWeb #BrightfieldGroup #RollUp #Consolidation #Business #FexingoBusiness #BusinessPodcast #TheBuyoutShow #Acquisitions #Cannabis #FDA #DietarySupplements #Valuation #MergersAndAcquisitions #LPs Keep every episode free: buymeacoffee.com/fexingo